Similar articles

• [Therapeutic standards and perspectives for stage IV non-small cell lung cancer].

  Reck M, Rosell R, Tiemann M. Reck M, et al. Onkologie. 2012;35 Suppl 3:10-3. doi: 10.1159/000338986. Epub 2012 May 15. Onkologie. 2012. PMID: 22678019 German. No abstract available.
• Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer.

  Lennes IT, Lynch TJ. Lennes IT, et al. Clin Lung Cancer. 2009 Sep;10(5):341-6. doi: 10.3816/CLC.2009.n.046. Clin Lung Cancer. 2009. PMID: 19808192 Review.
• The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer.

  Freeman RK, Van Woerkom JM, Vyverberg A, Ascioti AJ. Freeman RK, et al. Eur J Cardiothorac Surg. 2010 Jul;38(1):1-5. doi: 10.1016/j.ejcts.2010.01.051. Epub 2010 Mar 4. Eur J Cardiothorac Surg. 2010. PMID: 20206544
• [Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)].

  Eberhardt W, Fietkau R, Griesinger F, Passlick B, Stuschke M. Eberhardt W, et al. Onkologie. 2006 Sep;29 Suppl 2:7-10. doi: 10.1159/000094948. Epub 2006 Sep 6. Onkologie. 2006. PMID: 16974121 Review. German. No abstract available.
• Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.

  Hermens RP, Ouwens MM, Vonk-Okhuijsen SY, van der Wel Y, Tjan-Heijnen VC, van den Broek LD, Ho VK, Janssen-Heijnen ML, Groen HJ, Grol RP, Wollersheim HC. Hermens RP, et al. Lung Cancer. 2006 Oct;54(1):117-24. doi: 10.1016/j.lungcan.2006.07.001. Epub 2006 Aug 21. Lung Cancer. 2006. PMID: 16920220